Investors Research Corp’s Quest Diagnostics DGX Stock Holding History

Investors Research Corp’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,054	Closed	-$183K	–	870
2025 Q4	$183K	Hold	1,054	–	–	0.03%	303
2025 Q3	$201K	Buy	1,054 +45	+4%	+$7.99K	0.04%	298
2025 Q2	$181K	Hold	1,009	–	–	0.04%	311
2025 Q1	$171K	Hold	1,009	–	–	0.04%	313
2024 Q4	$152K	Hold	1,009	–	–	0.03%	337
2024 Q3	$157K	Hold	1,009	–	–	0.03%	341
2024 Q2	$138K	Hold	1,009	–	–	0.03%	358
2024 Q1	$134K	Hold	1,009	–	–	0.03%	369
2023 Q4	$139K	Hold	1,009	–	–	0.03%	374
2023 Q3	$123K	Hold	1,009	–	–	0.03%	377
2023 Q2	$142K	Hold	1,009	–	–	0.04%	365
2023 Q1	$143K	Hold	1,009	–	–	0.04%	366
2022 Q4	$158K	Hold	1,009	–	–	0.04%	358
2022 Q3	$124K	Hold	1,009	–	–	0.04%	366
2022 Q2	$134K	Hold	1,009	–	–	0.04%	363
2022 Q1	$138K	Hold	1,009	–	–	0.04%	364
2021 Q4	$175K	Hold	1,009	–	–	0.05%	324
2021 Q3	$147K	Hold	1,009	–	–	0.05%	333
2021 Q2	$133K	Hold	1,009	–	–	0.05%	345
2021 Q1	$129K	Hold	1,009	–	–	0.05%	350
2020 Q4	$120K	Hold	1,009	–	–	0.05%	388
2020 Q3	$116K	Hold	1,009	–	–	0.06%	361
2020 Q2	$115K	Hold	1,009	–	–	0.06%	338
2020 Q1	$81K	Hold	1,009	–	–	0.05%	361
2019 Q4	$108K	Hold	1,009	–	–	0.05%	397
2019 Q3	$108K	Hold	1,009	–	–	0.05%	385
2019 Q2	$103K	Hold	1,009	–	–	0.05%	374
2019 Q1	$91K	Buy	+1,009	New	+$87.4K	0.05%	405

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Investors Research Corp's DGX Position: Q1 2026 in Review

Investors Research Corp sold out of Quest Diagnostics (DGX) in Q1 2026, closing a stake of 1,054 shares — an estimated $183K sold.

Investors Research Corp first reported a position in DGX in Q1 2019 and held it in 28 quarters. The position peaked at $201K in Q3 2025. 1,067 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

Investors Research Corp reported no remaining Quest Diagnostics position as of Q1 2026 after selling out during the quarter.
Investors Research Corp sold 1,054 Quest Diagnostics shares in Q1 2026, an estimated $183K.
Investors Research Corp first reported a position in Quest Diagnostics in Q1 2019 and held it in 28 quarters.
Investors Research Corp's Quest Diagnostics position peaked at $201K in Q3 2025.
1,067 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Investors Research Corp's 13F filing for Q1 2026, filed 3 Apr 2026.